Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lineage Cell Therapeutics, Inc. (LCTX)
NYSE MKT:LCTX
Holding LCTX?
Track your performance easily
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 19, 2024 | xxxxxxxxxxxxx | $9345 | |
| May 28, 2024 | Brian Culley President & Ceo,director | xxxxxxxxxxxxx | $10500 |
| Feb 08, 2024 | Don Bailey Director | xxxxxxxxxxxxx | $100001 |
| Feb 08, 2024 | Broadwood Partners Lp Director, >10% Owner | xxxxxxxxxxxxx | $7000001 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $4526989 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 83,420,138 | Insider | 44.18% | 75,328,385 | |
| 34,093,007 | Insider | 18.05% | 30,785,985 | |
| 8,054,508 | Institution | 4.27% | 7,273,221 | |
| 7,231,398 | Institution | 3.83% | 6,529,952 | |
| 5,580,050 | Institution | 2.95% | 5,038,785 | |
| 5,002,198 | Institution | 2.65% | 4,516,985 | |
| 4,507,781 | Institution | 2.39% | 4,070,526 | |
| 1,717,469 | Institution | 0.91% | 1,550,875 | |
| 1,611,102 | Institution | 0.85% | 1,454,825 | |
| 894,040 | Institution | 0.47% | 807,318 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,231,398 | Institution | 3.83% | 6,529,952 | |
| 1,717,469 | Institution | 0.91% | 1,550,875 | |
| 1,611,102 | Institution | 0.85% | 1,454,825 | |
| 894,040 | Institution | 0.47% | 807,318 | |
| 745,591 | Institution | 0.39% | 673,269 | |
| 667,100 | Institution | 0.35% | 602,391 | |
| 416,223 | Institution | 0.22% | 375,849 | |
| 128,266 | Institution | 0.07% | 115,824 | |
| 128,074 | Institution | 0.07% | 115,651 | |
| 123,123 | Institution | 0.07% | 111,180 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,416,552 | Institution | 2.34% | 3,998,305 | |
| 3,926,716 | Institution | 2.08% | 3,546,610 | |
| 2,814,846 | Institution | 1.49% | 2,548,280 | |
| 1,316,289 | Institution | 0.70% | 1,188,872 | |
| 677,547 | Institution | 0.36% | 613,383 | |
| 337,045 | Institution | 0.18% | 304,419 | |
| 137,685 | Institution | 0.07% | 124,646 | |
| 81,397 | Institution | 0.04% | 72,036 | |
| 12,537 | Institution | <0.01% | 10,837 | |
| 7,878 | Institution | <0.01% | 7,132 |
FAQ
Who Owns Lineage Cell Therapeutics, Inc. (LCTX)?
Currently, no data Available
What percentage of Lineage Cell Therapeutics, Inc. (LCTX) stock is held by institutional investors?
Currently, no data Available
What percentage of Lineage Cell Therapeutics, Inc. (LCTX) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Lineage Cell Therapeutics, Inc. (LCTX)?
Broadwood Partners Lp owns the most shares of Lineage Cell Therapeutics, Inc. (LCTX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.